{"version":"1.0","type":"link","title":"Adverse event reporting patterns associated with Degarelix and Relugolix: a pharmacovigilance study based on the FAERS database.","author_name":"Luo J 외","author_url":"https://prs-insight.online/author/Luo%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/130589","thumbnail_width":1200,"thumbnail_height":630}